These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25738454)

  • 1. GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.
    Koehler JA; Baggio LL; Yusta B; Longuet C; Rowland KJ; Cao X; Holland D; Brubaker PL; Drucker DJ
    Cell Metab; 2015 Mar; 21(3):379-91. PubMed ID: 25738454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
    Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
    Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.
    Fesler Z; Mitova E; Brubaker PL
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32147716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R.
    Yusta B; Baggio LL; Koehler J; Holland D; Cao X; Pinnell LJ; Johnson-Henry KC; Yeung W; Surette MG; Bang KW; Sherman PM; Drucker DJ
    Diabetes; 2015 Jul; 64(7):2537-49. PubMed ID: 25735732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
    Yusta B; Holland D; Waschek JA; Drucker DJ
    Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-binding protein-4 inhibits epithelial growth and proliferation in the rodent intestine.
    Austin K; Tsang D; Chalmers JA; Maalouf MF; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G206-G219. PubMed ID: 29631376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
    Koehler JA; Harper W; Barnard M; Yusta B; Drucker DJ
    Cancer Res; 2008 Oct; 68(19):7897-904. PubMed ID: 18829546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.
    Yusta B; Holland D; Koehler JA; Maziarz M; Estall JL; Higgins R; Drucker DJ
    Gastroenterology; 2009 Sep; 137(3):986-96. PubMed ID: 19523469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.
    Taqi E; Wallace LE; de Heuvel E; Chelikani PK; Zheng H; Berthoud HR; Holst JJ; Sigalet DL
    J Pediatr Surg; 2010 May; 45(5):987-95. PubMed ID: 20438940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "cryptic" mechanism of action of glucagon-like peptide-2.
    Rowland KJ; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G1-8. PubMed ID: 21527727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.
    Dong CX; Zhao W; Solomon C; Rowland KJ; Ackerley C; Robine S; Holzenberger M; Gonska T; Brubaker PL
    Endocrinology; 2014 Feb; 155(2):370-9. PubMed ID: 24265452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
    Koehler JA; Kain T; Drucker DJ
    Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor.
    Kedees MH; Guz Y; Grigoryan M; Teitelman G
    Peptides; 2013 Oct; 48():36-44. PubMed ID: 23927844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin-4 does not modify growth or apoptosis of human colon cancer cells.
    Wenjing H; Shuang Y; Weisong L; Haipeng X
    Endocr Res; 2017 Aug; 42(3):209-218. PubMed ID: 28318339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.
    Bahrami J; Yusta B; Drucker DJ
    Gastroenterology; 2010 Jun; 138(7):2447-56. PubMed ID: 20226187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
    Dubé PE; Forse CL; Bahrami J; Brubaker PL
    Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.
    Hsieh J; Longuet C; Baker CL; Qin B; Federico LM; Drucker DJ; Adeli K
    Diabetologia; 2010 Mar; 53(3):552-61. PubMed ID: 19957161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.
    Dubé PE; Rowland KJ; Brubaker PL
    Endocrinology; 2008 Jan; 149(1):291-301. PubMed ID: 17884945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.